Literature DB >> 11366249

Metabolic complications of protease inhibitors: what have we learned so far?

E J Erbelding.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 11366249

Source DB:  PubMed          Journal:  Hopkins HIV Rep        ISSN： 1551-8396


× No keyword cloud information.
  1 in total

1.  The development of metabolic risk factors after the initiation of the second line anti- retroviral therapy.

Authors:  Apoorva Mittal; Basavaprabhu Achappa; Deepak Madi; Mukta N Chowta; John T Ramapuram; Satish Rao; B Unnikrishnan; Soundarya Mahalingam
Journal:  J Clin Diagn Res       Date:  2013-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.